Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
John A. Carter, Xingyue Huang, Khurram Jamil, Shelby Corman, Varun Ektare & John Niewoehner. (2023) Cost-effectiveness of terlipressin for hepatorenal syndrome: the United States hospital perspective. Journal of Medical Economics 26:1, pages 1342-1348.
Read now
Read now
Amanda Chaney. (2021) A Review for the Practicing Clinician: Hepatorenal Syndrome, a Form of Acute Kidney Injury, in Patients with Cirrhosis. Clinical and Experimental Gastroenterology 14, pages 385-396.
Read now
Read now
Jagmeet Singh, Dushyant Singh Dahiya, Asim Kichloo, Gurdeep Singh, Katayoun Khoshbin & Hafeez Shaka. (2021) Hepatorenal syndrome: a Nationwide Trend Analysis from 2008 to 2018. Annals of Medicine 53:1, pages 2018-2024.
Read now
Read now
Articles from other publishers (21)
Xingyue Huang, Jas Bindra, Ishveen Chopra, John Niewoehner & George J. Wan. (2023) Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function. Advances in Therapy 40:12, pages 5432-5446.
Crossref
Crossref
Jun Cheol Choi & Jeong-Ju Yoo. (2023) Hepatorenal Syndrome. The Korean Journal of Gastroenterology 82:5, pages 224-232.
Crossref
Crossref
Muhammad A. Mujtaba, Ann Kathleen Gamilla-Crudo, Shehzad N. Merwat, Syed A. Hussain, Michael Kueht, Aftab Karim, Muhammad W. Khattak, Peggy J. Rooney & Khurram Jamil. (2023) Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older. Annals of Hepatology 28:5, pages 101126.
Crossref
Crossref
Andrea Bejjani, Youqi Zhang, Allison Behrens, Brian Murray & Neil Shah. (2022) Droxidopa in the Management of Hepatorenal Syndrome. Journal of Pharmacy Practice 36:4, pages 1030-1034.
Crossref
Crossref
Katherine M Cooper, Alessandro Colletta, Kristen Moulton, Kenneth M Ralto & Deepika Devuni. (2023) Kidney disease in patients with chronic liver disease: Does sex matter?. World Journal of Clinical Cases 11:17, pages 3980-3992.
Crossref
Crossref
Matthew R. Thau & Pavan K. Bhatraju. (2023) Following the MAP for Improved Kidney Function in Hepatorenal Syndrome. Kidney360 4:4, pages e427-e428.
Crossref
Crossref
Ashwani K. Singal, Yong‐Fang Kuo, K. Rajender Reddy, Ramon Bataller & Paul Kwo. (2022)
Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis‐related hospitalisations in the
US
. Alimentary Pharmacology & Therapeutics 56:10, pages 1486-1496.
Crossref
Crossref
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis RostJr.Jr., Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot & Jonathan Soldera. (2022) Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterología y Hepatología 45:1, pages 25-39.
Crossref
Crossref
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis RostJr.Jr., Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot & Jonathan Soldera. (2022) Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterología y Hepatología (English Edition) 45:1, pages 25-39.
Crossref
Crossref
Khurram Jamil, Xingyue Huang, David Hayashida & Kunal Lodaya. (2022) The Hepatorenal Syndrome Patient Pathway: Retrospective Analysis of Electronic Health Records. Current Therapeutic Research 96, pages 100663.
Crossref
Crossref
Songtao Liu, Qinghua Meng, Yuan Xu & Jianxin Zhou. (2021) Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion. Gastroenterology Report 9:6, pages 505-520.
Crossref
Crossref
Irtiza Hasan, Tasnuva Rashid, Razvan M Chirila, Peter Ghali & Hani M. Wadei. (2021) Hepatorenal syndrome: pathophysiology and evidence-based management update. Romanian Journal of Internal Medicine 59:3, pages 227-261.
Crossref
Crossref
Surain B. Roberts, Bettina E. Hansen, Saeha Shin, Lusine Abrahamyan, Lauren Lapointe‐Shaw, Harry L. A. Janssen, Fahad Razak, Amol A. Verma & Gideon M. Hirschfield. (2021) Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort. Alimentary Pharmacology & Therapeutics 54:5, pages 689-698.
Crossref
Crossref
Steven L. Flamm, Kimberly Brown, Hani M. Wadei, Robert S. Brown, Marcelo Kugelmas, Milagros Samaniego‐Picota, Patrizia Burra, Fred Poordad & Sammy Saab. (2021) The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin. Liver Transplantation 27:8, pages 1191-1202.
Crossref
Crossref
Sophie McAllister, Jennifer C. Lai, Timothy P. Copeland, Kirsten L. Johansen, Charles E. McCulloch, Yuenting D. Kwong, Divya Seth, Barbara Grimes & Elaine Ku. (2021) Renal Recovery and Mortality Risk among Patients with Hepatorenal Syndrome Receiving Chronic Maintenance Dialysis. Kidney360 2:5, pages 819-827.
Crossref
Crossref
Seungwon Lee, Chelsea Doktorchik, Elliot Asher Martin, Adam Giles D'Souza, Cathy Eastwood, Abdel Aziz Shaheen, Christopher Naugler, Joon Lee & Hude Quan. (2021) Electronic Medical Record–Based Case Phenotyping for the Charlson Conditions: Scoping Review. JMIR Medical Informatics 9:2, pages e23934.
Crossref
Crossref
Yaser Khalid, Neethi Dasu, Raja Fawad Zafar, Herman Suga, Kirti Dasu & Brian Blair. (2020) In-Hospital Outcomes of Patients With Pulmonary Hypertension and Cirrhosis: A 6-Year Population Cohort Study of Over One Million Patients. Cardiology and Therapy 9:2, pages 479-492.
Crossref
Crossref
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis RostJr.Jr., Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot & Jonathan Soldera. (2020) Predicting mortality for hepatorenal syndrome with liver‐specific scores. GastroHep 2:6, pages 336-343.
Crossref
Crossref
Kevin Moore, Khurram Jamil, Katharina Verleger, Linlin Luo, Nehemiah Kebede, Marieke Heisen, Shelby Corman, Roberta Leonardi, Rachel Bakker, Christine Maï, Nisreen Shamseddine, Xingyue Huang & Andrew S. Allegretti. (2020) Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Alimentary Pharmacology & Therapeutics 52:2, pages 351-358.
Crossref
Crossref
Raseen Tariq & Ashwani K. Singal. (2020) Management of Hepatorenal Syndrome: A Review. Journal of Clinical and Translational Hepatology 8:2, pages 192-199.
Crossref
Crossref
Joseph F. Dasta & Sandra Kane-Gill. (2019) Review of the Literature on the Costs Associated With Acute Kidney Injury. Journal of Pharmacy Practice 32:3, pages 292-302.
Crossref
Crossref